WANDA BEARING
920002
CG MED EQUIP.
838810
SUZHOUBEARING
430418
4
COCYBER
835207
5
Guangdong Create Century Intelligent Equipment Group Corporation
300083
US Stock MarketDetailed Quotes
JNJ Johnson & Johnson
- 163.080
- -3.010-1.81%
Close Feb 26 16:00 ET
- 163.080
- 0.0000.00%
Post 18:25 ET
392.63BMarket Cap28.17P/E (TTM)
165.130High162.555Low11.39MVolume165.080Open166.090Pre Close1.86BTurnover0.47%Turnover Ratio28.17P/E (Static)2.41BShares166.43052wk High5.49P/B392.03BFloat Cap138.67752wk Low4.91Dividend TTM2.40BShs Float170.855Historical High3.01%Div YieldTTM1.55%Amplitude12.137Historical Low163.292Avg Price1Lot Size
About Johnson & Johnson Company
Johnson & Johnson is a holding company, which engages in the research, development, manufacture, and sale of products in the healthcare field. It operates through the Innovative Medicine and MedTech segments. The Innovative Medicine segment focuses on immunology, infectious diseases, neuroscience, oncology, cardiovascular and metabolism, and pulmonary hypertension. The MedTech segment includes a portfolio of products used in the interventional solutions, orthopaedics, surgery, and vision categories. The company was founded by Robert Wood Johnson I, James Wood Johnson, and Edward Mead Johnson Sr. in 1887 and is headquartered in New Brunswick, NJ.
Company Profile
SymbolJNJ
Company NameJohnson & Johnson
Listing DateSep 25, 1944
Founded1887
CEOMr. Joaquin Duato
MarketNYSE
Employees138100
Fiscal Year Ends12-28
AddressOne Johnson & Johnson Plaza
CityNew Brunswick
ProvinceNew Jersey
CountryUnited States of America
Zip Code08933
Phone1-732-524-0400
Websitehttp://www.jnj.com
Company Executives
- Name
- Position
- Salary
- Joaquin Duato
- Chairman of the Board and Chief Executive Officer
- 28.40M
- Robert J. Decker, Jr
- Controller and Chief Accounting Officer
- --
- Kathryn E. Wengel
- Executive Vice President and Chief Technical Operations & Risk Officer
- --
- Joseph J. Wolk, C.P.A.
- Executive Vice President and Chief Financial Officer
- 13.91M
- Kristen Mulholland
- Executive Vice President and Chief Human Resources Officer
- --
- Elizabeth Forminard
- Executive Vice President and Chief Legal Officer
- --
- James D. Swanson
- Executive Vice President and Chief Information Officer
- --
- Jennifer L. Taubert
- Executive Vice President and Worldwide Chairman, Innovative Medicine
- 11.00M
- Dr. John C. Reed,M.D.,PhD
- Executive Vice President, Innovative Medicine, R&D
- 20.65M
- Vanessa Broadhurst
- Executive Vice President, Global Corporate Affairs
- --
- Timothy Schmid
- Executive Vice President and Worldwide Chairman, MedTech
- --
- Marillyn A. Hewson
- Independent Director
- 360.00K
- Dr. Nadja Y West, M.D.
- Independent Director
- 340.00K
- Eugene A. Woods
- Independent Director
- 89.15K
- Mark A. Weinberger
- Independent Director
- 340.00K
- Dr. Mark B. McClellan, M.D.,PhD
- Independent Director
- 320.00K
- Dr. Mary C. Beckerle, PhD
- Independent Director
- 355.00K
- Anne M. Mulcahy
- Lead Independent Director
- 410.00K
- Dr. Jennifer A. Doudna, PhD
- Independent Director
- 320.00K
- Dr. Paula A. Johnson,M.D.
- Independent Director
- 352.97K
- Hubert Joly
- Independent Director
- 320.00K
- Darius E. Adamczyk
- Independent Director
- 340.00K
Trending Stocks
Discussing
Tesla's earnings caused fluctuations, what's your market outlook？
Tesla's Q4 2024 revenue was $25.71 billion, up 2% year-on-year but below expectations. Can Tesla's stock price keep rising in 2025 with Trum
Moo Earnings
Jan 24 10:26
TSLA earnings preview: Grab rewards by guessing the opening price!